Showing results (41-50 of 282) with videos related to

Sort By:
Pageof 29
Antimicrobial Agents and Chemotherapy|July 1, 1989
Treatment of Clostridium difficile-associated disease with teicoplaninF de Lalla, G Privitera, E Rinaldi, et al.
Annali Sclavo; Rivista Di Microbiologia E Di Immunologia|September 1, 1979
[Diffusion of intestinal parasitic diseases in some Milanese kindergartens]E Clerici, F Ghezzi, F Palmaro, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1990
HIV, HBV, delta-agent and Treponema pallidum infections in two rural African areasF de Lalla, G Rizzardini, E Rinaldi, et al.
Current Pharmaceutical Design|July 29, 2004
Therapy of chronic hepatitis C virus infection in HIV co-infected peopleP Fabris, E Barnes, G Tositti, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2002
Serum pepsinogen and gastrin levels in HIV-positive patients: relationship with CD4+ cell count and Helicobacter pylori infectionP Fabris, A Pilotto, L Bozzola, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1992
Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDSF de Lalla, R Maserati, P Scarpellini, et al.
Diabetes Care|August 11, 2000
Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infectionC Betterle, P Fabris, R Zanchetta, et al.
Alimentary Pharmacology & Therapeutics|October 30, 1999
Interferon alfa-2b alone or in combination with ketoprofen as treatment for interferon-naive chronic hepatitis C patientsP Fabris, G Tositti, F Negro, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1992
Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrheaF de Lalla, R Nicolin, E Rinaldi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1995
Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short periodF de Lalla, G Pellizzer, A Vaglia, et al.
Pageof 29